UPDATED Oct 06, 2025
Explore the Belgian (BEL20) Biggest Losers Today. These stocks have seen the largest drop in Market Cap from the previous trading day.
| Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
VAN | €31.00 | 1.6% | 2.8% | €387.6m | €35.75 | PE12.1x | E4.3% | 7.7% | Consumer Durables | ||
PROX | €7.32 | 0.3% | 8.0% | €2.4b | €8.18 | PE4.1x | E-9.4% | 8.2% | Telecom | ||
ECONB | €1.75 | 2.2% | -12.9% | €292.3m | €2.27 | PE7.4x | E22.5% | 5.7% | Software | ||
CAMB | €237.00 | 2.2% | 166.3% | €355.5m | n/a | PE7.5x | n/a | 1.9% | Materials | ||
IBAB | €11.10 | 3.0% | -18.3% | €324.9m | €16.67 | PE19.2x | E25.9% | 2.2% | Healthcare | ||
EXM | €10.30 | 1.2% | 11.4% | €819.0m | n/a | PE6.2x | n/a | 27.7% | Energy | ||
GIMB | €46.60 | 0.8% | 15.1% | €1.7b | €50.33 | PE7.8x | n/a | 5.6% | Diversified Financials | ||
NYXH | €4.85 | 10.1% | -42.3% | €181.4m | €12.30 | PS36.8x | E17.4% | n/a | Healthcare | ||
VIO | €7.84 | 1.0% | 43.3% | €2.0b | n/a | PE11x | n/a | 2.0% | Materials | ||
CENER | €13.24 | 0.8% | 35.1% | €2.8b | €13.61 | PE15.8x | E11.2% | 1.1% | Capital Goods | ||
UMI | €15.25 | 0.8% | 31.8% | €3.7b | €14.02 | PE28.5x | E20.8% | 3.3% | Materials | ||
BREB | €107.80 | 0.9% | -1.3% | €3.2b | €130.00 | PE63.1x | n/a | 1.3% | Diversified Financials | ||
CMBT | €8.07 | 1.5% | -48.9% | €2.3b | €10.45 | PE11.3x | E32.3% | 75.0% | Energy | ||
LOTB | €7,910.00 | 0.6% | -33.8% | €6.4b | €9,635.71 | PE40.2x | E11.0% | 1.0% | Food, Beverage & Tobacco | ||
SOF | €251.60 | 0.6% | 2.8% | €8.3b | €315.00 | PE20.1x | n/a | 1.4% | Diversified Financials | ||
ARGX | €679.80 | 0.2% | 41.7% | €41.6b | €721.13 | PE38.1x | E26.4% | n/a | Pharmaceuticals & Biotech | ||
DEME | €130.60 | 2.7% | -10.1% | €3.3b | €167.71 | PE10.1x | E3.4% | 2.9% | Capital Goods | ||
TUB | €229.00 | 2.0% | 73.5% | €10.2b | €201.75 | PE109.9x | n/a | 0.5% | Pharmaceuticals & Biotech | ||
UCB | €253.20 | 0.5% | 53.3% | €48.1b | €238.67 | PE36.1x | E17.9% | 0.5% | Pharmaceuticals & Biotech |